Precision medicine using microbiota

@article{Jobin2018PrecisionMU,
  title={Precision medicine using microbiota},
  author={Christian Jobin},
  journal={Science},
  year={2018},
  volume={359},
  pages={32-34}
}
Accumulating evidence indicates that dysregulation of microbiota-host interactions associates with various diseases, including inflammatory bowel diseases (IBDs), colorectal cancer, diabetes, and liver cirrhosis (1). Recently, research has generated paradigm shifts in concepts about the interactions between bacteria and cancer therapeutic drugs. For example, bacteria modulate the antitumor efficacy in preclinical models of various chemotherapies (2–4) and immunotherapeutic agents (5, 6… CONTINUE READING